These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 23039140)
1. Efficacy of inpatient treatment for atopic dermatitis evaluated by changes in serum cortisol levels. Fukuda H; Suzuki T; Saotome A; Sode E; Mukai H J Dermatol; 2013 Jan; 40(1):43-7. PubMed ID: 23039140 [TBL] [Abstract][Full Text] [Related]
2. Low basal serum cortisol in patients with severe atopic dermatitis: potent topical corticosteroids wrongfully accused. Haeck IM; Timmer-de Mik L; Lentjes EG; Buskens E; Hijnen DJ; Guikers C; Bruijnzeel-Koomen CA; de Bruin-Weller MS Br J Dermatol; 2007 May; 156(5):979-85. PubMed ID: 17298484 [TBL] [Abstract][Full Text] [Related]
3. Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis. Fujisawa T; Nagao M; Hiraguchi Y; Katsumata H; Nishimori H; Iguchi K; Kato Y; Higashiura M; Ogawauchi I; Tamaki K Pediatr Allergy Immunol; 2009 Nov; 20(7):633-41. PubMed ID: 19236603 [TBL] [Abstract][Full Text] [Related]
4. Association of serum interleukin-18 and other biomarkers with disease severity in adults with atopic dermatitis. Kou K; Aihara M; Matsunaga T; Chen H; Taguri M; Morita S; Fujita H; Yamaguchi Y; Kambara T; Ikezawa Z Arch Dermatol Res; 2012 May; 304(4):305-12. PubMed ID: 22146836 [TBL] [Abstract][Full Text] [Related]
5. Topical clofibrate improves symptoms in patients with atopic dermatitis and reduces serum TARC levels: a randomized, double-blind, placebo-controlled pilot study. Fukaya M; Kimata H J Drugs Dermatol; 2014 Mar; 13(3):259-63. PubMed ID: 24595568 [TBL] [Abstract][Full Text] [Related]
6. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. Kakinuma T; Nakamura K; Wakugawa M; Mitsui H; Tada Y; Saeki H; Torii H; Asahina A; Onai N; Matsushima K; Tamaki K J Allergy Clin Immunol; 2001 Mar; 107(3):535-41. PubMed ID: 11240957 [TBL] [Abstract][Full Text] [Related]
7. Correlation between serum thymus and activation-regulated chemokine levels and stratum corneum barrier function in healthy individuals and patients with mild atopic dermatitis. Furue M; Matsumoto T; Yamamoto T; Takeuchi S; Esaki H; Chiba T; Yamaguchi H J Dermatol Sci; 2012 Apr; 66(1):60-3. PubMed ID: 22391243 [TBL] [Abstract][Full Text] [Related]
8. Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis. Kataoka Y J Dermatol; 2014 Mar; 41(3):221-9. PubMed ID: 24628072 [TBL] [Abstract][Full Text] [Related]
9. Are age-specific high serum IgE levels associated with worse symptomatology in children with atopic dermatitis? Hon KL; Lam MC; Leung TF; Wong KY; Chow CM; Fok TF; Ng PC Int J Dermatol; 2007 Dec; 46(12):1258-62. PubMed ID: 18173519 [TBL] [Abstract][Full Text] [Related]
10. Serum levels of thymus and activation-regulated chemokine can be used in the clinical evaluation of atopic dermatitis. Gu CY; Gu L; Dou X Int J Dermatol; 2015 Jul; 54(7):e261-5. PubMed ID: 26108268 [TBL] [Abstract][Full Text] [Related]
11. Reduction of serum TARC levels in atopic dermatitis by topical anti-inflammatory treatments. Yasukochi Y; Nakahara T; Abe T; Kido-Nakahara M; Kohda F; Takeuchi S; Hagihara A; Furue M Asian Pac J Allergy Immunol; 2014 Sep; 32(3):240-5. PubMed ID: 25268342 [TBL] [Abstract][Full Text] [Related]
12. Effect of an antiallergic drug (Olopatadine hydrochloride) on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis. Furukawa H; Takahashi M; Nakamura K; Kaneko F J Dermatol Sci; 2004 Dec; 36(3):165-72. PubMed ID: 15541638 [TBL] [Abstract][Full Text] [Related]
13. Adrenocortical function in patients with severe atopic dermatitis. Matsuda K; Katsunuma T; Iikura Y; Kato H; Saito H; Akasawa A Ann Allergy Asthma Immunol; 2000 Jul; 85(1):35-9. PubMed ID: 10923602 [TBL] [Abstract][Full Text] [Related]
14. Serum thymus and activation-regulated chemokine (TARC) and interleukin-31 levels as biomarkers for monitoring in adult atopic dermatitis. Kyoya M; Kawakami T; Soma Y J Dermatol Sci; 2014 Sep; 75(3):204-7. PubMed ID: 24984931 [No Abstract] [Full Text] [Related]
15. Serum Thymus and Activation Regulated Chemokine (TARC), IL- 18 and IL-18 Gene Polymorphism as Associative Factors with Atopic Dermatitis. Gohar MK; Atta AH; Nasr MM; Hussein DN Egypt J Immunol; 2017 Jun; 24(2):9-22. PubMed ID: 29528575 [TBL] [Abstract][Full Text] [Related]
16. Association study of transition of laboratory marker levels and transition of disease activity of atopic dermatitis patients treated with dupilumab. Mizuno M; Horiguchi G; Teramukai S; Ichiyama S; Ito M; Hoashi T; Kanda N; Saeki H Australas J Dermatol; 2021 Nov; 62(4):e504-e509. PubMed ID: 34523731 [TBL] [Abstract][Full Text] [Related]
17. Utility of serum thymus and activation-regulated chemokine as a biomarker for monitoring of atopic dermatitis severity. Landheer J; de Bruin-Weller M; Boonacker C; Hijnen D; Bruijnzeel-Koomen C; Röckmann H J Am Acad Dermatol; 2014 Dec; 71(6):1160-6. PubMed ID: 25199679 [TBL] [Abstract][Full Text] [Related]
18. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. Hijnen D; De Bruin-Weller M; Oosting B; Lebre C; De Jong E; Bruijnzeel-Koomen C; Knol E J Allergy Clin Immunol; 2004 Feb; 113(2):334-40. PubMed ID: 14767451 [TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of CCR4 ligands in relation to clinical severity of atopic dermatitis in Egyptian children. Mostafa GA; Tomoum HY; Salem SA; Abd El-Aziz MM; Abou El-Maged DI; El-Sayed El-Far I Pediatr Allergy Immunol; 2008 Dec; 19(8):756-62. PubMed ID: 18435706 [TBL] [Abstract][Full Text] [Related]
20. Cortisol and adrenocorticotropic hormone dynamics in the acute phase of subarachnoid haemorrhage. Zetterling M; Engström BE; Hallberg L; Hillered L; Enblad P; Karlsson T; Ronne Engström E Br J Neurosurg; 2011 Dec; 25(6):684-92. PubMed ID: 22115015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]